The Agency requires the purchase of purified hyperimmune Equine Tetanus Antitoxin for use in the development of a replacement biological reference material.
An overview of the requirement is: hyperimmune equine tetanus antitoxin obtained from the repeated immunisation of horses with tetanus toxoid and toxin. The suitable material would have a potency of at least 1,500 IU/ml in a total volume of not less than 5 L and will be purified F(ab)2. Material to be supplied in 2019. As far as we are aware there is only one supplier who is able to meet this very specific request. Potential suppliers if they feel they can meet the requirement should email Nawaz.firstname.lastname@example.org to register an interest.
If no submissions of potential interest are received by close of play 14 March 2019, it is then intended to perform a direct award without competition to the sole supplier we believe can deliver the required service.